Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Nuvig Therapeutics Inc.

United States 3450 Hillview Avenue Suite 200, 94304-1394, United States

About the sponsor

Nuvig Therapeutics Inc. is engaged in clinical research for chronic inflammatory demyelinating polyneuropathy, with interest in immune-mediated disorders that affect peripheral nerve function and motor-sensory control.

  • CIDP
  • Peripheral neuropathy
  • Immune-mediated demyelination

The sponsor’s work in this area centers on therapeutic development for neuromuscular disability associated with inflammatory nerve injury.

About Specializations

Nuvig Therapeutics Inc. runs clinical trials in conditions such as Immune thrombocytopenia, Chronic inflammatory demyelinating polyradiculoneuropathy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Immune thrombocytopenia

Recruiting
Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:NVG-2089
  • Sponsor:Nuvig Therapeutics Inc.

Chronic inflammatory demyelinating polyradiculoneuropathy

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:NVG-2089
  • Sponsor:Nuvig Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.